BioHealth News Archive
Join BHI and Represent the BioHealth Capital Region in the FRAXA Biotech Games™ for Research
Are you seeking an opportunity to engage your firm in a fun community-building activity? Register one or more teams for the FRAXA Biotech Games. …
Read MoreUnique Team-Building and Promotion for your BioHealth Company: FRAXA Biotech Games™ for Research
Are you seeking an opportunity to engage your firm in a fun community-building activity? Register one or more teams for the FRAXA Biotech Games. …
Read MoreNearly 40 Maryland Companies, Universities Working on Vaccines, Therapeutics, Diagnostic Tests, and Clinical Research
ANNAPOLIS, MD—Governor Larry Hogan today commended the nearly 40 Maryland life sciences companies that are working on developing and manufacturing COVID-19 vaccines and therapeutics,…
Read MoreMaryland’s 8th District Leads US in Science and Engineering Jobs, Study Says | Montgomery Community Media
Maryland’s 8th Congressional District has the highest proportion of science and engineering jobs in its workforce out of any district in the United States,…
Read More5 Questions with Judy Costello, Managing Director of Economic Development for BioHealth Innovation, Inc. (BHI) · BioBuzz
“5 Questions With……” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little…
Read MoreMaryland Legislators Urge More Aggressive Use of Antibody Tests as Local Company Aims to Advance Research – NBC4 Washington
Maryland's Department of Health announced Thursday it will partner with 13 hospitals around the state to launch an antibody study on unused blood samples.…
Read MoreCARMA Cell Therapies™ Expands Phase I Trial of Anti-Mesothelin mRNA CAR-PBMC Cell Therapy MCY-M11
GAITHERSBURG, MD, AUGUST 18, 2020 — MaxCyte, Inc., a global cell-based therapies and life sciences company, today announces the expansion of subsidiary CARMA Cell…
Read MoreNovavax COVID-19 vaccine enters second round of human trials | Live Science
The biotechnology company Novavax will soon begin the second phase of human testing for its COVID-19 vaccine. The so-called phase 2b clinical trial will…
Read MoreRanked: The 10 US Cities Best Positioned To Recover From Coronavirus (And The 10 Worst)
The coronavirus pandemic has impacted cities across the country with varying force. New York City has been hardest hit, and it’s no secret that…
Read MoreNovavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine | Novavax Inc. – IR Site
GAITHERSBURG, Md., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases,…
Read MoreOrganoPlate® Graft: The Missing Link In Tissue Culture
The OrganoPlate® Graft is the first in vitro cell culture platform that allows vascularization of 3D tissues like spheroids, organoids, and tumors in vitro. In this webinar, you will…
Read MoreMaryland Commercial Real Estate Services | Scheer Partners
(Rockville, MD – August 20, 2020) - Scheer Partners is proud to announce that 704 Quince Orchard Road, Gaithersburg, Maryland is 100% leased. In…
Read MoreAdaptive Phage Therapeutics Announces Mayo Clinic as Lead Investor in Convertible Note Financing – BioHealth Capital Region
GAITHERSBURG, Md.–(BUSINESS WIRE)–Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant…
Read MoreRegister now for Women Building Bio 2020
Women Building Bio is where the vision is transformed into reality. Women advancing the industry with all stakeholders, men and women, front and center…
Read MoreNose is a key entryway for coronavirus, Hopkins study shows – Baltimore Sun
The cells that allow people to smell are a key entryway for the coronavirus, making nose coverings crucial, suggests new research from the Johns…
Read More